A new market study, titled “Tissue Engineering – Global Market Outlook (2017-2023)”, has been featured on WiseGuyReports.
According to research report, the Global Tissue Engineering market is expected to grow from $7.06 billion in 2016 to reach $16.82 billion by 2023 with a CAGR of 13.2%. Growing usage of tissue engineering as an alternative for organs is the major factor propelling the market growth. In addition, recent technological advancements, encouraging government initiatives, and huge investments in R&D are the some of the key factors fostering the market growth. On the other hand, strict regulations for approvals, time taking process to develop a tissue & high costs are the constraints limiting the market growth.
Among all the applications, orthopedic segment leads the market globally with the biggest market share and is expected to grow with a higher CAGR during the forecast period. The growth of this segment is attributed to growing geriatric population and raising incidence of reconstructive and replacement surgeries. Neurology segment is likely to witness faster growth rate due to increasing research & development. North America is emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S. Asia Pacific is expected to witness high growth rate during the forecast period.
Some of the key players in global tissue engineering market include Acelity, CryoLife, ReproCell Inc., Stryker Corporation, Medtronic Inc., Integra LifeSciences, RTI Surgical Inc., Acell Inc, Organogenesis Inc, Zimmer Biomet, Athersys Inc, Sanofi, AastromBioSciences, BioMemetic Therapeutics, Tissue Regenix Group Plc, and Advanced Cell Technology.
Applications Covered:
- Orthopedics, musculoskeletal and spine
- Cardiology & vascular
- Neurology
- Dental
- Cord blood & cell banking
- GI & gynecology
- Skin/integumentary
- Urology
- Cancer
- Other Applications
Request Sample report at https://www.wiseguyreports.com/sample-request/2769009-tissue-engineering-global-market-outlook-2017-2023
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Argentina
o Brazil
o Chile
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Tissue Engineering Market, By Application
6 Global Tissue Engineering Market, By Geography
7 Key Developments
8 Company Profiling
8.1 Acelity
8.2 CryoLife
8.3 ReproCell Inc.
8.4 Stryker Corporation
8.5 Medtronic Inc.
8.6 Integra LifeSciences
8.7 RTI Surgical Inc.
8.8 Acell Inc
8.9 Organogenesis Inc
8.10 Zimmer Biomet
8.11 Athersys Inc
8.12 Sanofi
8.13 AastromBioSciences
8.14 BioMemetic Therapeutics
8.15 Tissue Regenix Group Plc
8.16 Advanced Cell Technology
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)